Karyopharm Therapeutics | 股票

金融业

USD

USD 96.23M

现金及等价物

USD 37.67M

USD 37.43M

USD 89.75M

USD 87.16M

USD 264.09M

股息收益率

0

USD -26.28M

USD -26.2M

325

EPS每股收益

USD -0.15

股本和储备

USD -269.26M

USD -30.78M

债务利息支出

USD 11.38M

USD -0.15

USD -0.93

USD 1.08B

USD -30.78M

USD 61.82M

USD -31.28M

普通股股本

USD 13K

USD -30.89M

USD 30.54M

销售和管理费用

USD 27.19M

USD 3.97M

贸易债权人

USD 5.39M

应收帐款人

USD 31.78M

	股票	更改		日
AbbVie	USD 4.95B		13M	2025-12
Abbott	USD 6.49B		220M	2025-12
Amgen	USD 6.22B		121M	2025-12
AstraZeneca	USD 6.59B		126M	2025-09
BioCryst Pharmaceuticals	USD 5.23M		188K	2025-09
Bristol-Myers Squibb	USD 2.76B		21M	2025-09
Eli Lilly	USD 13.74B		1.56B	2025-12
GlaxoSmithKline	GBP 6.12B		46M	2025-09
Incyte	USD 101.06M		17.61M	2025-12
J&J	USD 14.19B		45M	2025-12
Karyopharm Therapeutics	USD 3.97M		1.03M	2025-09
MacroGenics	USD 8.75M		530K	2025-09
Merck	USD 6.44B		157M	2025-09
Nektar Therapeutics	USD 14.46M		1.78M	2024-06
Novartis	USD 6.42B		114M	2025-09
Novartis	USD 6.42B		114M	2025-09
Pfizer	USD 11.47B		201M	2025-09
Regeneron Pharmaceuticals	USD 3.2B		53.6M	2025-12
Roche Holding	CHF 7.6B		9M	2025-06
Takeda	JPY 1.41T		107.71B	2025-12
TG Therapeutics	USD 125.59M		21.37M	2025-12
Ultragenyx Pharmaceutical	USD 52.2M		5.7M	2025-09

Karyopharm Therapeutics 股票 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.